TR
Tasleem R Kalburgi
About Tasleem R Kalburgi
Data last updated:
Tasleem R Kalburgi is a Managing Director at Wimak Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Wimak Pharmaceuticals Private Limited reported revenue of ₹5.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wimak Pharmaceuticals Private Limited U24239KA2022PTC163541 | Managing Director | 07 Jul 2022 | 2022 | ₹5.5 Lakh (FY 2024) | Active |
Board colleagues of Tasleem R Kalburgi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naushin Fatma | 09666779 | Wimak Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tasleem R Kalburgi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tasleem R Kalburgi
Tasleem R Kalburgi currently holds 1 directorship: Wimak Pharmaceuticals Private Limited (Managing Director, since 07 Jul 2022, revenue ₹5.5 Lakh (FY 2024)).
Tasleem R Kalburgi was first appointed on 07 Jul 2022 as Managing Director at Wimak Pharmaceuticals Private Limited.
The current boards of Tasleem R Kalburgi's companies include Naushin Fatma (Wimak Pharmaceuticals Private Limited).